RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2

https://w3id.org/ripe/ripe-kg/work/10.1097%2F01.cnd.0000211401.19995.a2
SubjectPredicateObject
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report prism:doi 10.1097/01.cnd.0000211401.19995.a2
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report dcterms:title Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report rdf:type node1
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report rdf:type rdfs:Resource
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report rdf:type owl:Thing
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report rdf:type prov:Entity
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report rdf:type ripe:WorkWork
ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report owl:sameAs https://semopenalex.org/work/W1966349236
ripekg:work/10.1136%2Fbmj-2025-084290Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial http://purl.org/spar/cito/cites ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report
ripekg:work/10.1136%2Fbmj-2025-084290Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies http://purl.org/spar/cito/cites ripekg:work/10.1097%2F01.cnd.0000211401.19995.a2Small-fiber neuropathy associated with capecitabine (Xeloda)-induced hand-foot syndrome: a case report